Survival is Significantly Poorer for Young Black Patients With AML Compared With White Counterparts - OncLive

Despite receiving similar treatment, Black patients between the ages of 18 and 29 years with acute myeloid leukemia were twice as likely to die within 5 years compared with Whites.

Despite receiving similar treatment, Black patients between the ages of 18 and 29 years with acute myeloid leukemia (AML) were twice as likely to die within 5 years compared with Whites, according to… [+4748 chars]

full article...